advertisement

Topcon

Gedde SJ 30

Showing records 1 to 25 | Display all abstracts from Gedde SJ

65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Prum BE
Ophthalmology 2016; 123: P112-51
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Olmos LC
Eye 2016; 30: 463-472
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Prum BE
Ophthalmology 2016; 123: P41-P111
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Panarelli JF
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Sayed MS
Eye 2016; 30: 463-472
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Rosenberg LF
Ophthalmology 2016; 123: P41-P111
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Lim MC
Ophthalmology 2016; 123: P112-51
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Banitt MR; Gedde SJ
Ophthalmology 2016; 123: 789-795
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Gedde SJ
Ophthalmology 2016; 123: P41-P111
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Mansberger SL
Ophthalmology 2016; 123: P112-51
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Moraczewski AL
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Shi W
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Gedde SJ
Eye 2016; 30: 463-472
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Stein JD
Ophthalmology 2016; 123: P112-51
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Mansberger SL
Ophthalmology 2016; 123: P41-P111
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Moroi SE
Ophthalmology 2016; 123: P112-51
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Rosenfeld PJ
Eye 2016; 30: 463-472
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Stein JD
Ophthalmology 2016; 123: P41-P111
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Schiffman JC
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Shi W
Eye 2016; 30: 463-472
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Gedde SJ
Ophthalmology 2016; 123: P112-51
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Feuer WJ
Ophthalmology 2016; 123: 789-795
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Moroi SE
Ophthalmology 2016; 123: P41-P111
65911 Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern(®) Guidelines
Herndon LW
Ophthalmology 2016; 123: P112-51
65912 Primary Open-Angle Glaucoma Preferred Practice Pattern(®) Guidelines
Herndon LW
Ophthalmology 2016; 123: P41-P111

Issue 17-3

Change Issue


advertisement

Oculus